The effect of Medicare Part D on drug and medical spending. - Wikidata - wikimedia - TriplyDB

The effect of Medicare Part D on drug and medical spending.

The effect of Medicare Part D on drug and medical spending.

http://www.wikidata.org/entity/Q33810332

about

The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review Cognition and take-up of subsidized drug benefits by Medicare beneficiaries.Medicare Part D--lessons learned and guidance for health-care reform.Falling into the coverage gap: Part D drug costs and adherence for Medicare Advantage prescription drug plan beneficiaries with diabetes How the Medicare Part D drug benefit changed the distribution of out-of-pocket pharmacy spending among older beneficiaries.The Medicare drug benefit (Part D) and treatment of heart failure in older adults.Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review Pharmaceutical innovation: impact on expenditure and outcomes and subsequent challenges for pharmaceutical policy, with a special reference to Greece.Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D.Incident user cohorts for assessing medication cost-offsets The impact of Medicare Part D on medication treatment of hypertension.From the patient perspective: the economic value of seasonal and H1N1 influenza vaccination.The impact of Medicare prescription drug coverage on the use of antidementia drugs.Medication cost problems among chronically ill adults in the US: did the financial crisis make a bad situation even worse?Medicare part D and changes in prescription drug use and cost burden: national estimates for the Medicare population, 2000 to 2007 The impact of Medicare Part D on hospitalization rates Drug benefit changes under Medicare Advantage Part D: heterogeneous effects on pharmaceutical use and expenditures Racial and ethnic disparities among enrollees in Medicare Advantage plans.Osteoporosis care in the United States after declines in reimbursements for DXA.Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression.A Welfare Measure of "Offset Effects" in Health Insurance.Beneficiaries with cardiovascular disease and thePart D coverage gap.Geographic variation in Medicare drug spending Effects of Medicare Part D coverage gap on medication and medical treatment among elderly beneficiaries with depression.Medicare Part D's effect on the under- and overuse of medications: a systematic review.Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap.Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance.Fixing flaws in Medicare drug coverage that prompt insurers to avoid low-income patients The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure Cost-effectiveness of Medicare drug plans in schizophrenia and bipolar disorder.Medicare Part D and potentially inappropriate medication use in the elderly.Did Medicare Part D Affect National Trends in Health Outcomes or Hospitalizations? A Time-Series Analysis.Cost sharing and decreased branded oral anti-diabetic medication adherence among elderly Part D Medicare beneficiaries.Adverse clinical events among medicare beneficiaries using antipsychotic drugs: linking health insurance benefits and clinical needs Effects of Medicare Part D coverage gap on medication adherence.Medicare Part D plan generosity and medication use among dual-eligible nursing home residents.Ambulatory antibiotic use and prescription drug coverage in older adults.The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries Digesting the doughnut hole.

P2860

Q28238484-8049C52E-9D45-4543-9EC2-AAC29867AF6F Q28541457-037718FC-BF06-47A8-8399-AE87992F6CA9 Q33355816-39EA16BE-54E6-4885-838C-93F10DBE9C92 Q33611440-8E3CCA23-CC7A-4058-9B50-FD93CB5BE2E0 Q33725773-74961A37-C7C5-4E01-BE58-333ABC230330 Q33906706-5C237CFE-885E-40F9-882D-E9F3D1310F93 Q33967679-66D5CAC8-3E81-412E-95EC-4F07D3DE0AF8 Q34158480-B41B17F0-00BC-4DBF-8812-4B51D927E8D8 Q34361406-9B8E031D-1153-4EF0-9C40-3471E5A24419 Q34509195-E025B2E8-9190-41D1-86F4-FCAEA301656F Q34553899-5BAD7D0B-CBB6-4C19-A5B2-BCAF6D697CAB Q34554697-85CC6C86-18EC-4F9D-8B36-4E22D38F4CC8 Q34613417-2A7E3076-F61D-4740-9D0F-89D0938A7618 Q34690333-C38DBADC-BED5-464C-B28A-F14C04C3A539 Q34957623-2749370C-5F0B-4689-BD0F-EF9C878FB94B Q35151469-BFEC815B-6333-444E-A60A-C60C706AF5D2 Q35190976-6179DC01-B4DC-44D3-82D7-D46AFC688F66 Q35235565-7D5A3878-B935-4FAB-A01E-0B5B03DDA4F4 Q35238299-1D0D1F27-CA2B-41F8-869A-6DB0D030D2B4 Q35570975-A58E68F6-0841-40C4-A57D-6DD13F2A6C87 Q35602002-204CF0B3-34DE-4394-9441-3767AD845D2D Q35913842-AA4685C7-9890-45AA-8683-7AC99072048F Q35992856-74B8B2DB-25F1-429B-BCE1-712BC13B1B7B Q35999455-04D72AC9-74CD-43A9-8A82-6937A30BB8AD Q36079132-19BD5E71-1B43-4BF3-8F81-3B77523E6F92 Q36105740-8564589F-C7D7-4E5F-9CD1-3CE94554CC4B Q36108381-E1711D0D-28C3-43A4-AF27-77F7C8972858 Q36165497-E2A6A192-2D41-414F-9F53-32FBA20E0665 Q36174579-888C1E55-4ABD-4929-BAA8-04774F921194 Q36318602-5EB251A2-6A40-4F44-95C4-4B852AE0980B Q36660803-E273AB5A-3E81-4AAB-B783-33DF49F767E5 Q36755390-56ED6BBF-51E4-49B1-A2DF-BD8316185AD5 Q36826952-5733FF4E-5E9C-4C32-ABB1-EAD16486D1D0 Q36927439-5D603D85-468C-4EA0-830A-704AD08AD016 Q36942823-B801A3CC-6502-4C60-9A10-1DB78D849673 Q37013366-C3A86DAE-70F2-427D-9B84-74420B99EB99 Q37171080-B2293435-B1B8-4636-BE9A-C6B774C191EF Q37199714-70921AB3-35A8-4C91-8EC8-81EBB54F2921 Q37266094-AAD9352C-970D-4F3E-B6BB-56A0E8B17F12 Q37374576-26E4D915-0C58-4CCB-9198-5C77C0670449

P2860

The effect of Medicare Part D on drug and medical spending.

http://www.wikidata.org/entity/Q33810332

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

The effect of Medicare Part D on drug and medical spending.

@ast

The effect of Medicare Part D on drug and medical spending.

@en

type

label

The effect of Medicare Part D on drug and medical spending.

@ast

The effect of Medicare Part D on drug and medical spending.

@en

prefLabel

The effect of Medicare Part D on drug and medical spending.

@ast

The effect of Medicare Part D on drug and medical spending.

@en

P1433

Q33810332-A013BE6B-6E88-48CD-8D41-9AF5BC69AED3

P1476

Q33810332-E2B7DD3F-E306-44D8-8086-30E12394051D

P2093

Q33810332-128009B1-A65E-45C3-8141-17F3984433F7

Q33810332-2D1464D8-FA38-4221-892D-23A4D536CFAC

Q33810332-FE1C2600-5FE2-4FB7-B1D8-120425875C1F

P2860

Q33810332-3835D285-D751-4909-8D8F-EAD3D329C187

Q33810332-5BEF46B5-AE72-4269-AAC5-9E6272CE09DD

Q33810332-6829A2C1-B52A-444F-922D-B4E3AC57962E

Q33810332-7DB73946-EB87-4851-95E7-062C54E1B538

Q33810332-7DF614A8-8070-4B58-A7A7-CA25282D1A44

Q33810332-83CB2CEC-CD87-4CF9-8813-DC0D0549EAC8

Q33810332-8BE306BF-F0AE-4DB3-A072-B340E7E80529

Q33810332-9C4FED85-FA03-4DAC-8CA0-A876C0D50D53

Q33810332-AA86808D-74B1-4FFA-83BF-165FD58DE3D4

Q33810332-BA6D9CFB-FFFA-42AF-920C-DE622DC498BC

P304

Q33810332-F5C5F722-505D-421E-B58D-A05073CE504D

P31

Q33810332-E2346A1F-2612-46BC-B9F2-821B3F147E55

P356

Q33810332-FFB11223-7D24-4D88-A0F1-8DDFB115F11A

P407

Q33810332-3271EC18-73A3-4B77-9DB7-B91EB4F70138

P433

Q33810332-BA3D8A3D-4D6C-4515-BA21-9302E50BC79E

P478

Q33810332-B53BED9B-AA7B-49CC-9A96-EA19C75DA7BF

P50

Q33810332-73483444-0DBF-4FC6-9DDC-794BB4F1FC8F

Q33810332-CDE0054C-0217-44DC-A956-06336214A6B3

P577

Q33810332-5675C8B4-6688-4EE9-8B9F-301EA3A62C2B

P698

Q33810332-99ED1B38-DEF3-44FF-920F-8AA704EA9402

P932

Q33810332-C86FA27F-A6CB-4230-84A3-4C7E8572E87B

P356

P1433

The New England Journal of Medicine

P1476

The effect of Medicare Part D on drug and medical spending.

@en

P2093

Gerald O'Donnell

http://www.w3.org/2001/XMLSchema#string

Joseph P Newhouse

http://www.w3.org/2001/XMLSchema#string

Judith R Lave

http://www.w3.org/2001/XMLSchema#string

P2860

Should patients receive secondary prevention medications for free after a myocardial infarction? An economic analysis

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

Risk adjustment of Medicare capitation payments using the CMS-HCC model.

Inappropriate prescribing for elderly Americans in a large outpatient population.

Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.

Adverse events associated with prescription drug cost-sharing among poor and elderly persons.

Cost-effectiveness of full medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes.

Unintended consequences of caps on Medicare drug benefits.

Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes.

Marginal structural models as a tool for standardization.

P304

52-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMSA0807998

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19571283

http://www.w3.org/2001/XMLSchema#string

P932

2859614

http://www.w3.org/2001/XMLSchema#string